Normal and Malignant Hematopoiesis
New Advances
Herausgegeben:Mihich, Enrico; Metcalf, Donald
Normal and Malignant Hematopoiesis
New Advances
Herausgegeben:Mihich, Enrico; Metcalf, Donald
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
''An exciting glance at key issues in contemporary hematopoiesis.'' - The Quarterly Review of Biology
Andere Kunden interessierten sich auch für
- Molecular Biology of Hematopoiesis 542,99 €
- Leukocyte Integrins in the Immune System and Malignant Disease74,99 €
- Chronic Myelocytic Leukemia and Interferon83,99 €
- Molecular Aspects of Myeloid Stem Cell Development83,99 €
- DNA Tumor Viruses147,99 €
- Corona- and Related Viruses43,99 €
- WhettonBlood Cell Biochemistry246,99 €
-
-
-
''An exciting glance at key issues in contemporary hematopoiesis.'' -The Quarterly Review of Biology
Produktdetails
- Produktdetails
- Pezcoller Foundation Symposia 6
- Verlag: Springer / Springer US / Springer, Berlin
- Artikelnr. des Verlages: 978-1-4613-5789-6
- Softcover reprint of the original 1st ed. 1995
- Seitenzahl: 260
- Erscheinungstermin: 21. November 2012
- Englisch
- Abmessung: 254mm x 178mm x 15mm
- Gewicht: 496g
- ISBN-13: 9781461357896
- ISBN-10: 1461357896
- Artikelnr.: 37478034
- Pezcoller Foundation Symposia 6
- Verlag: Springer / Springer US / Springer, Berlin
- Artikelnr. des Verlages: 978-1-4613-5789-6
- Softcover reprint of the original 1st ed. 1995
- Seitenzahl: 260
- Erscheinungstermin: 21. November 2012
- Englisch
- Abmessung: 254mm x 178mm x 15mm
- Gewicht: 496g
- ISBN-13: 9781461357896
- ISBN-10: 1461357896
- Artikelnr.: 37478034
1. Regulation of Normal Hemopoiesis.- 2. Cytokine Regulation of Lymphohemopoietic Progenitors.- 3. Hematopoietic Stem Cells.- 4. Transcriptional Control of Hematopoietic Development: Roles of GATA-Factors.- 5. Rearrangement of the ALL1 Gene in Acute Myeloid Leukemia without Chromosomal Translocations.- 6. Non-Receptor Protein Tyrosine Kinases: Pivotal Regulatory Molecules Controlling Lymphopoiesis.- 7. The Regulation and Function of p21Ras in T Cell Activation and Growth.- 8. Irf-1 Functions as a Tumor Suppressor: Possible Involvement in Human Myelodysplasia and Leukemia.- 9. A Family of High Molecular Weight Proteins Active in Differentiation and Growth Control.- 10. Hematopoietic Signaling by the Cytokine Receptor Superfamily.- 11. Positive and Negative Growth Effects of Abl Genes.- 12. Advances in the Understanding of the Molecular Pathogenesis of Aggressive B Cell Lymphomas.- 13. Structure and Expression Pattern of the PML Gene.- 14. Contribution of the Cyclin D1 Gene to Lymphomagenesis.- 15. Clinical Results of All-trans Retinoic Acid: A Targeted Drug for Differentiation Treatment in Acute Promyelocytic Leukemia.- 16. Induction of Alloantigen Specific T Cell Anergy by Inhibition of the B7:CD28 Pathway.- 17. Novel Strategies for Cancer Treatment through Modulation of Proimmune and Proinflammatory Cytokines.- 18. Concluding Comments.
1. Regulation of Normal Hemopoiesis.- 2. Cytokine Regulation of Lymphohemopoietic Progenitors.- 3. Hematopoietic Stem Cells.- 4. Transcriptional Control of Hematopoietic Development: Roles of GATA-Factors.- 5. Rearrangement of the ALL1 Gene in Acute Myeloid Leukemia without Chromosomal Translocations.- 6. Non-Receptor Protein Tyrosine Kinases: Pivotal Regulatory Molecules Controlling Lymphopoiesis.- 7. The Regulation and Function of p21Ras in T Cell Activation and Growth.- 8. Irf-1 Functions as a Tumor Suppressor: Possible Involvement in Human Myelodysplasia and Leukemia.- 9. A Family of High Molecular Weight Proteins Active in Differentiation and Growth Control.- 10. Hematopoietic Signaling by the Cytokine Receptor Superfamily.- 11. Positive and Negative Growth Effects of Abl Genes.- 12. Advances in the Understanding of the Molecular Pathogenesis of Aggressive B Cell Lymphomas.- 13. Structure and Expression Pattern of the PML Gene.- 14. Contribution of the Cyclin D1 Gene to Lymphomagenesis.- 15. Clinical Results of All-trans Retinoic Acid: A Targeted Drug for Differentiation Treatment in Acute Promyelocytic Leukemia.- 16. Induction of Alloantigen Specific T Cell Anergy by Inhibition of the B7:CD28 Pathway.- 17. Novel Strategies for Cancer Treatment through Modulation of Proimmune and Proinflammatory Cytokines.- 18. Concluding Comments.